RxDoctor Payments Data

William Duke, DPM

Podiatrist · Jefferson City, MONPI 1629016902

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $32,759 of the $54,473 with a category attached, or 60.1%. Treace Medical Concepts, Inc. accounts for 93.7% of it on its own, with 6 other manufacturers making up the rest. Among podiatrist clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,473in general payments, 2019–2025

Across 130 payments — averaging $419.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$51K
  • Celularity Inc.$3K
  • Organogenesis Inc.$220
  • Stryker$154
  • Comsort, Inc$100
  • Bioventus LLC$28
  • plus $20 from 1 others
$93,914in research payments, 2019–2025

Across 15 payments — averaging $6260.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endo Pharmaceuticals Inc.$94K

What the payments were for

  • Consulting fees$32,75960%
  • Travel & lodging$6,82813%
  • Food & beverage$2,8425%
  • Charitable contribution$12,04422%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Treace Medical Concepts, Inc.106$51,041
Celularity Inc.4$2,910
Organogenesis Inc.12$220
Stryker4$154
Comsort, Inc1$100
Bioventus LLC2$28
Elite Orthopedics, LLC1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,473 in reported general payments places this provider in the 95th percentile of 105 podiatrist providers in Missouri.

See all podiatrist providers in Missouri

Medicare billing

Part B allowed, 2024
$82,150
Medicare patients
251
Services billed
772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin15$2,566
Gabapentin57$1,130
Cephalexin94$668
Terbinafine Hcl23$603
Prochlorperazine Maleate57$391
Acetaminophen-CodeineAcetaminophen With Codeine48$354
Methylprednisolone22$139
Meloxicam56$118
Clindamycin Hcl12$74
Tramadol Hcl12$47

Paid to pharmacies, not to this prescriber.

Other podiatrist in Jefferson City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →